IGC Pharma (IGC) Asset Utilization Ratio (2011 - 2025)
IGC Pharma (IGC) posted quarterly Asset Utilization Ratio of 0.13 for Q3 2025, up 10.81% year-over-year from 0.11 in Q3 2024, and down 21.35% quarter-over-quarter from 0.16 in Q2 2025.
IGC Pharma (IGC) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported Asset Utilization Ratio for 15 consecutive years, with 0.13 the latest figure, recorded in Q3 2025.
- In Q3 2025, Asset Utilization Ratio rose 10.81% year-over-year to 0.13; the TTM figure through Sep 2025 stood at 0.13 (up 10.81% YoY), while the FY2026 annual figure was 0.04, down 74.06% from the prior year.
- Asset Utilization Ratio retreated to 0.13 in Q3 2025 per IGC's latest filing, from 0.16 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.16 in Q2 2025 and bottomed at 0.01 in Q3 2021.
- Historically, Asset Utilization Ratio has averaged 0.07 across 5 years, with a median of 0.08 in 2023.
- Annual changes were most pronounced in 2021 — Asset Utilization Ratio slumped 89.41% — and 2022, when it soared 277.81%.
- IGC Pharma's Asset Utilization Ratio stood at 0.01 in 2021, then jumped by 277.81% to 0.04 in 2022, then surged by 112.06% to 0.09 in 2023, then surged by 45.12% to 0.13 in 2024, then slipped by 1.61% to 0.13 in 2025.
- Business Quant data shows IGC's Asset Utilization Ratio at 0.13 in Q3 2025, 0.16 in Q2 2025, and 0.14 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.47 |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.38 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.20 |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.69 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.90 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.54 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.13 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.13 |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.13 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.14 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.10 |
| Mar 31, 2024 | 0.13 |
| Dec 31, 2023 | 0.09 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.05 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.03 |
| Dec 31, 2020 | 0.03 |